SARS powerpoint

Embed Size (px)

Citation preview

  • 7/27/2019 SARS powerpoint

    1/44

    CAP-MRCommunityAcquired

    Pneumonia Moderate Risk

    Prepared by:

    Sheena Marie Germinal

  • 7/27/2019 SARS powerpoint

    2/44

  • 7/27/2019 SARS powerpoint

    3/44

    General objectives:

    Within 6 days of related learning experience,I will be able to apply my knowledge, skillsand attitude regarding the concept cellular

    aberrations.

    Specific objectives:Within 8 hours of exposure I will be able to:

  • 7/27/2019 SARS powerpoint

    4/44

    Knowledge

    1.) Identify the different illness in the area ofexposure in order to give appropriate nursinginterventions.

    2.) Provide information about the medications ofthe client.3.) State the exact rationale for every nursingintervention.

    4.) Formulate a comprehensive nursing care plan.5.) Provide appropriate health teaching for myclient.

  • 7/27/2019 SARS powerpoint

    5/44

    Skills

    1.) Organize data properly to ensure a systematicdata collection.2.) Gather relevant data needed in formulating theplan of care.

    3.) Construct a data analysis using initial data base.4.) Develop teaching plan to achieve wellnesspromotion.5.) List down important information and answersgiven by client which is necessary in planning aneffective nursing care.

  • 7/27/2019 SARS powerpoint

    6/44

    Attitude

    1.) Display a good role model to my fellow classmatesto the folks and my client.2.) Follow consciously all rules and regulation of thehospital.

    3.) Show respect to the staff, clinical instructor andmy fellow classmates.4.) Seek clinical instructors guide before renderingany procedure.5.) Display Augustinian values at all times especiallyhonesty in doing any procedures and telling thetruth.

  • 7/27/2019 SARS powerpoint

    7/44

    Prepared By:Frestine Joanne Ibon

  • 7/27/2019 SARS powerpoint

    8/44

    I. Vital Information

    Name: J.LAddress: Poblacion Ilawod Lambunao, IloiloBirth Date: April 2, 1982

    Gender: FemaleMarital Status: MarriedReligion: Roman CatholicDate and Time of Admission: October 1, 2013 @ 5 a.m.Physician: Dr. S.

    Chief complaint: Cough and Difficulty of BreathingAdmitting Diagnosis: CAP, MR

  • 7/27/2019 SARS powerpoint

    9/44

    II. History of Present Illness

    Two months prior to admission the client

    experienced exertional dyspnea but she did not made

    any intervention to this. Then two weeks prior to

    admission she is experiencing non productive cough andincreased severity of exertional dyspnea. The following

    day client went on a hilot nearby and was advised to

    take some herbal plants. Thereafter, when she noticed

    that her cough is not minimizing she decided to go to

    WVSUMC and admitted in San Vicente Ferrer Ward andundergone different tests like CBC, platelet, protime, 12-

    L ECG, Blodd typing, Urinalysis, creatinine, S. K+ and Na+,

    and CT Scan.

  • 7/27/2019 SARS powerpoint

    10/44

    III. Past Medical History

    J.L. has no history of hospitalization. Received a

    complete immunizations. She have not committed any

    childhood accidents. She also had no food, drug, and

    environmental allergies. She had suffered fromchildhood illnesses such as fever and runny nose that

    would last at least three days as far as she could

    remember. She takes over the counter drugs such as 1

    tab of biogesic to relieve the pain and discomfort and

    herbal medicines such as lapunaya that her motherwould use to hampol. She takes 1tab of Enervon every

    day before hours of sleep as his vitamin supplement.

  • 7/27/2019 SARS powerpoint

    11/44

    Disease Paternal Maternal

    Asthma x

    Hypertension x DM

    Cancer x x

  • 7/27/2019 SARS powerpoint

    12/44

    V. Socioeconomic Status

    J.L is a highschool physics Teacher, married with a college Rizal teacher

    with 3 children aging 6 months, 2 and 3 years. The number of their family

    members who are living in their house is 6 which includes her mother who took

    care of their children when they are at work.

    The family earns Php 10,000.00and above monthly. They live in a bungalow stylehouse, semi-concrete, with galvanized roof. There are two rooms, a kitchen and a

    comfort room separated from their house. They store foods in their refrigerator.

    They get water from the their own deep well and buys mineral water as their

    source of drinking. They sometimes celebrate fiesta in accordance to their

    budget. They always go to church every Sunday and sometimes participate in

    their barangay activities. He claims to have a mutual relationship with his

    neighbors because some of them were his childhood friends and he also claimed

    that he has a good and happy life with his family.

  • 7/27/2019 SARS powerpoint

    13/44

    VI. Activities of Daily Living

    A. Nutrition

    Client eats three times a day with no difficulty. At Breakfast, she usually

    drinks a cup of coffee while she dips 3-5 pieces of hot pandesal. During lunch, she

    prefers to eat vegetables and fish, sometimes meat and chicken if available with 3-4

    cups of rice per meal. By the time supper arrives, she eats canned goods and steamedvegetables like okra together with a cup of rice. He drinks 10-12 glasses of water a

    day.

    B. Elimination

    She urinates 3-7 times a day, her urine is pale straw and the amount of her

    urine depends on how much he usually takes. She defecates thrice a week, usually7am in the morning. Her stools are brown and well-formed as he claimed. She has no

    difficulty or pain felt upon urination and defecation.

  • 7/27/2019 SARS powerpoint

    14/44

    C. Rest and SleepClient sleeps after dinner at around 9pm and wakes up at 4am with a

    single pillow he usually puts under his head and in a side lying position while

    sleeping. When she cant sleep he watches television or listening to radio or drinking

    3-4 glasses of fermented coconut chucks.

    D. Activity and ExerciseShe refers doing household chores and school works as her exercise. When

    she hears a pop music over the radio, he would tend to sway his hips and stretch his

    arms and dance to the beat of the tune, that is if shes inside of their house.

  • 7/27/2019 SARS powerpoint

    15/44

    Drug

    Study

  • 7/27/2019 SARS powerpoint

    16/44

    CLASSIFICATION ACTION CONTRA

    -INDICATIONS

    PRECAUTIONS SIDE EFFECTS NURSING

    RESPONSIBILITY

    Corticosteroid enters target cells andbindsto cytoplasmic

    receptor;initiates

    many

    complexreactions that

    are responsiblefor

    its anti-

    inflammatory,immuno

    suppressive(glucocorti

    coid), and salt-

    retaining

    (mineralocorticoid)acti

    ons. Some actions

    maybe undesirable,

    dependingon drug

    use.

    Allergy to

    anycomponent of

    the drug- Fungal

    infections-

    Amebiasis- Hepatitis

    B- Vaccinia or

    varicella- Antibiotic-

    resistantinfections-

    Immunosuppression

    kidney disease- Liver

    disease- Cirrhosis-

    Hypothyroidism-

    Ulcerative colitis

    withimpending

    perforation-

    Diverticulitis- Recent

    GI surgery- Active or

    latent pepticulcer -

    Inflammatory

    boweldisease-

    Hypertension- Heart

    failure-

    Thromboembolicten

    dencies-

    Osteoporosis-

    Convulsivedisorders-

    Metastatic

    carcinoma- Diabetes

    mellitus- TB-

    Lactation

    Vertigo,

    headache,paresthesi

    as,

    insomnia,seizures,

    psychosis

    - Give daily before

    9am to mimicnormal

    peak

    diurnal corticosteroi

    dlevels.- Space

    multiple doses

    evenlythroughout

    the day.- Use

    minimal doses for

    minimalduration to

    minimize adverse

    effects.- Do not give

    IM injections if

    patienthas

    thrombocytopenic

    purpura.- Taper

    doses whendiscontinuinghigh-

    dose or long-term

    therapy

    Generic Name: Hydrocortisone

    Brand Name: Hydrocortone

  • 7/27/2019 SARS powerpoint

    17/44

    CLASSIFICATION ACTION CONTRA

    -INDICATIONS

    PRECAUTIONS SIDE EFFECTS NURSING

    RESPONSIBILITY

    Treatment ofhospitalized infantsand young children

    with severelower respiratory tra

    ct infections dueto respiratory

    syncytial virus.

    act as an analogue ofthese cellularmetabolites

    contraindicated inindividuals who

    have shownhypersensitivity to

    the drug or itscomponents, and inwomen who are or

    may becomepregnant duringexposure to the

    drug

    USE OF AEROSOLIZEDVIRAZOLE IN PATIENTS

    REQUIRINGMECHANICALVENTILATOR

    ASSISTANCE SHOULDBE UNDERTAKEN ONLY

    BY PHYSICIANS ANDSUPPORT STAFF

    FAMILIAR WITH THESPECIFIC VENTILATORBEING USED AND THIS

    MODE OFADMINISTRATION OF

    THE DRUG. STRICTATTENTION MUST BE

    PAID TO PROCEDURESTHAT HAVE BEEN

    SHOWN TO MINIMIZETHE ACCUMULATION

    OF DRUG PRECIPITATE,WHICH CAN RESULT IN

    MECHANICALVENTILATOR

    DYSFUNCTION ANDASSOCIATEDINCREASED

    PULMONARYPRESSURES

    fever, chills, bodyaches, flu

    symptoms;severe pain in upperstomach spreading

    to your back,nausea and

    vomiting, fast heartrate;

    stabbing chest pain,wheezing,

    hallucinations,thoughts of suicidechest pain or heavy

    feeling, painspreading to the

    arm or shoulder,nausea,dark colored urine,

    easy bruising orbleeding, confusion,

    or unusualweakness.

    Observe 10 Rs.Take this

    medication bymouth, usuallytwice daily with

    food for 24 to 48weeks or as

    directed by yourdoctor. Swallowthis medicationwhole. Do notcrush, break or

    chew the tablet.The dosage and

    length of treatmentis based on your

    age, weight,medical condition,and response to

    therapy.

    Generic Name: Ribavirin

    Brand Name: Virazole

    AVAILABLE FORMS & Dosage: Tablets, 400 mg PO qAM, 600mg PO qPM

  • 7/27/2019 SARS powerpoint

    18/44

    CLASSIFICATION ACTION CONTRA

    -INDICATIONS

    PRECAUTIONS SIDE EFFECTS NURSING

    RESPONSIBILITY

    Antiviral,neuraminidase

    inhibitor

    Severely inhibitsinfluenza virus

    neuraminidase, byblocking the actionsof this enzyme there

    is decreased viralrelease from infected

    cells, increasedformation of viralaggregates, and

    decreased spread ofvirus.

    treatment ofuncomplicated

    acute illness due toinfluenza virus (a or

    b) in adults andchildren who havebeen symptomaticfor 2 days or less.

    Prevention ofnaturally occurringinfluenza A and B inadults and children

    in close contactwith the flu.

    Allergy to anycomponent of drug.Use cautiously with

    pregnancy,lactation, asthma,

    COPD

    nausea, vomiting,diarrhea;

    dizziness, headache;nosebleed;

    eye redness ordiscomfort;

    sleep problems(insomnia); orcough or other

    respiratorysymptoms

    Instruct your clientnot take Tamiflu ifyou are allergic to

    the main ingredient,oseltamivir

    phosphate, or toany other

    ingredients ofTamiflu.

    Report severediarrhea, severe

    nausea, worseningof respiratory

    symptoms

    Generic Name: Oseltamivir

    Brand Name: Tamiflu

    AVAILABLE FORMS & Dosage: Oral suspension 12.5 mL. Capsule of 75 mg

  • 7/27/2019 SARS powerpoint

    19/44

    CLASSIFICATION ACTION CONTRA

    -INDICATIONS

    PRECAUTIONS SIDE EFFECTS NURSING

    RESPONSIBILITY

    Protease Inhibitors Exhibits antiviralactivity, inhibits HIV

    protease activity,

    leading to the

    decrease of HIV

    particles, inhibits

    metabolism of

    lopinavir, allowing for

    increased plasma

    levels of lopinavir

    patients withpreviously

    demonstratedclinically significant

    hypersensitivity(e.g., toxicepidermal

    necrolysis, Stevens-Johnson syndrome,

    erythemamultiforme) to anyof its ingredients,including ritonavir

    KALETRA is an HIV-1protease inhibitor

    indicated incombination with

    other antiretroviralagents for the

    treatment of HIV-1infection in adults

    and pediatricpatients

    Pancreatitis,Hepatotoxicity,

    Diarrhea, nauseaand vomiting,

    abdominal pain,flatulence, insomnia

    Instruct client toeat before takingthe oral solution

    of medicationIn tablets, May

    be taken with orwithout food,

    swallowed wholeand not chewed,

    broken, orcrushed

    Generic Name: Lopinavir / Ritonavir

    Brand Name: Oseltamivir

  • 7/27/2019 SARS powerpoint

    20/44

    Laboratory

    ResultsPrepared By:Ma. Theresa Abanilla

  • 7/27/2019 SARS powerpoint

    21/44

    Pyuria- containing pus

    Blood Typing: O, Rh +

    Composition Results Normal Values Significance

    Physical Properties

    Protime: Normal

    Urinalysis

    Color

    Transparency

    Reaction (ph)STGR

    Pale Straw

    Hazy

    6.01.010

    Straw/Amber

    Clear

    4.5-7.81.001-1.035

    Normal

    Pyuria, Pacleriuria

    Phosphate in

    Urine

    Normal

    Normal

    Date: October 1, 2013

    Time: 5:00 PM

  • 7/27/2019 SARS powerpoint

    22/44

    Chemical Test

    Sugar

    Albumin

    Negative

    Negative

    Negative

    Negative

    Normal

    Normal

    Microscopic Findings:

    Pus cells

    RBC

    Amorphous Urates

    Squamous Epithelial

    cells

    0-2/hpf

    4-5/hpf

    Occasional

    few

    3-6/hpf

    0-3/hpf

    None

    15-20/hpf

    May indicate

    infection

    a disease

    condition is often

    present. One of themost common causesof RBC's in the urine, is

    infection or

    inflammation of the

    urinary tract itself (i.e.,

    cystitis).

    can be caused by

    gout

    Normal

  • 7/27/2019 SARS powerpoint

    23/44

    Hematology

    Composition Results Normal Values Significance

    Hemoglobin

    HematocritRBC

    WBC

    Platelet Count

    134 g/L

    0.40 L/L4.67 10^g/L

    11.21 10^g/L

    427 10^ g/L

    120-160 g/L

    0.37-0.47 g/L4.2-5.4 10^g/L

    4.5-11 10^ g/L

    150-450 10^g/L

    Normal

    Normal

    Normal

    Normal

    Normal

    Afebrile

    Composition Results Normal Values Significance

    O2 Saturation

    INR

    95%

    1.02

    95-99%

    2.0-3.0

    Normal

    blood clots more

    quickly than

    desired

    Chest: CT Scan

    Limit oral fluid intake to Liter per day

    Maintain to high back rest

    IVF to KVO

  • 7/27/2019 SARS powerpoint

    24/44

  • 7/27/2019 SARS powerpoint

    25/44

    MEDICAL & SURGICAL

    INTERVENTIONS

  • 7/27/2019 SARS powerpoint

    26/44

    MEDICAL interventions

    Ventilation with low tidal volumes (6 mL/kg of ideal body weight) in patients

    requiring mechanical ventilation secondary to bilateral pneumonia or acute

    respiratory distress syndrome (ARDS)

    High doses of steroids to reduce swelling in the lungs.

    Administer Antiviral, Antibiotic or Steroidal medications with proper

    prescription from physician.

    Endotracheal Tube

    Pharmacological

  • 7/27/2019 SARS powerpoint

    27/44

    Monitor Vital Signs.

    An IV route is established to provide an accessible means for emergency

    drug therapy.

    Suctioning and bronchial hygiene Pulmonary toilet may include active

    suction of secretions, chest physiotherapy, positioning to promote dependent

    drainage, and incentive spirometry to enhance elimination of purulent sputum

    and to avoid atelectasis.

  • 7/27/2019 SARS powerpoint

    28/44

    MEDICAL interventions

    Position the patient to semi- or high-fowlers position to minimize risk

    of aspiration.

    Be sure that all members of your household are washing their hands

    frequently with soap and hot water or using an alcohol-based hand rub.

    Wear disposable gloves if you will have direct contact with body fluids

    of a person with SARS. However, wearing gloves is not a substitute for

    good hand hygiene. After contact with body fluids of a person with SARS,

    remove the gloves, throw them out, and wash your hands. Do not wash

    or reuse the gloves.

    Non-Pharmacological

  • 7/27/2019 SARS powerpoint

    29/44

    Encourage the person with SARS to cover his or her mouth and nose with a

    tissue when coughing or sneezing. If possible, the infected person should wear a

    surgical mask during close contact with other people in the home. If the personwith SARS cannot wear a surgical mask, other members of the household should

    wear one when they are in the room with that person.

    Do not use silverware, towels, bedding, clothing, or other items that havebeen used by the person with SARS until these items have been washed with

    soap and hot water.

    Clean surfaces in the infected person's room and bathroom fixtures used by

    this person daily with a household disinfectant used according to the

    manufacturer's instructions. When cleaning, wear disposable gloves and dispose

    of them after use. Household utility gloves may also be used.

  • 7/27/2019 SARS powerpoint

    30/44

    Limit the number of people in the household to those who are essential for

    patient support. Other household members should either be relocated or

    minimize their contact with the infected person in the home. This is particularlyimportant for people at risk of serious complications of SARS (e.g., persons with

    underlying heart or lung disease, diabetes mellitus, older age).

    Unexposed people who do not have an essential need to be in the homeshould not visit.

    For 10 days after your last exposure to the person with SARS, keep a vigilant

    watch for signs of fever (i.e., measure your temperature twice daily), respiratory

    symptoms, and other early SARS symptoms. If you do not have any of these

    symptoms, you do not need to limit your activities outside the home. You may go

    to work, school, out-of-home childcare, church, or activities in other public areas.

  • 7/27/2019 SARS powerpoint

    31/44

    Follow any other instructions provided by local health authorities.

    If you start feeling sick, especially if you develop a fever, respiratory

    symptoms, or other early symptoms of SARS, contact your healthcare provider

    immediately, and tell the healthcare provider that you have had close contact

    with a SARS patient.

  • 7/27/2019 SARS powerpoint

    32/44

    surgical intervention

    Endotracheal insertion

    Endotracheal intubation is a medical procedure in

    which a tube is placed into the windpipe (trachea),through the mouth or the nose. In most emergencysituations it is placed through the mouth.

  • 7/27/2019 SARS powerpoint

    33/44

    Endotracheal intubation is done

    to:

    Open the airway to give oxygen, medication,or anesthesia

    Remove blockages from the airway

    Allow the doctor to get a better view of theupper airway

    Protect the lungs in certain patients

  • 7/27/2019 SARS powerpoint

    34/44

    Patient position

    The patient should be aligned without lateral deviation ofthe head or neck.

    The head should be extended on the neck with a pillow

    under the occiput. If cervical spine trauma is suspected,have an assistant provide in-line immobilization.

    The neck should be flexed to approximately 15 degrees onthe chest.

    Try to keep the external auditory meatus and sternalnotch in same horizontal plane (except infants or whencervical spine injury is present or suspected).

  • 7/27/2019 SARS powerpoint

    35/44

    Nursing

    Diagnosis

  • 7/27/2019 SARS powerpoint

    36/44

    As evidenced by: GOAL INTERVENTION EVALUATION

    Subjective:

    -I cant breath wellbecause of my chestpain, as verbalized by

    the patient.Objective:

    -Difficulty of breathing- Shortness of breath

    - Altered breath depth

    - Timing ratio; prolonged

    expiration phases

    - Altered chest excursion

    - Nasal flaring

    - Grunting

    v/s

    TEMP: 35.7 C

    BP: 120/80 mmHg

    RR: 23 cpmPR: 110 bpm

    After 4 hours of nursing

    intervention, the patient

    will able to do coping

    mechanisms to improve

    his breathing pattern

    After 4 hours of nursing

    intervention, the patient

    did the coping

    mechanisms to improve

    his breathing pattern

    Auscultate chest; to

    evaluate pressure and

    character of breath

    sounds

    - Administer oxygen at

    lowest concentration

    indicated and prescribed

    repiratory medicationfor

    management of

    underlying pulmonary

    condition

    As evidenced by: GOAL INTERVENTION EVALUATION

  • 7/27/2019 SARS powerpoint

    37/44

    y

    -Evaluate HOB or have

    client sit up in chair, as

    appropriate to promote

    physiologic ease of

    maximal inspiration

    - Encourage

    slower/deeper

    respirations, use purse

    lip technique, to assist

    client in taking control of

    the situation

    - Monitor pulse oximetry,

    as indicated to verify

    maintenance in oxygen

    saturation

    - Maintain calm attitude

    while dealing with the

    client to limit level of

    anxiety

  • 7/27/2019 SARS powerpoint

    38/44

    As evidenced by: GOAL INTERVENTION EVALUATION

    Subjective:

    - Questioning members

    of the Heath Care Team.

    - lack of questionsabout SARS- verbalizing inaccurate

    information

    Objective:

    - unaware of proper

    prevention methods- denial need to learn

    After 2 hours, thepxatient will be able toverbalize the diseaseprocess, transmission,

    treatment, andcomplications of SARS.

    1.) Provide informationabout diseasetransmission.

    2.) Provide informationabout diseaseprocess/complications.

    3.) Provide informationon treatments.

    4.) Provide informationon general protectionfrom SARS.

    After 2 hours of nursingintervention, the patientwill be able to verbalizethe disease process,

    transmission,treatment, andcomplications of SARS.

  • 7/27/2019 SARS powerpoint

    39/44

    As evidenced by: GOAL INTERVENTION EVALUATION

    Subjective:

    - general feeling of

    discomfort

    - body aches- headache- exposure to persons

    with SARS

    Objective:

    - Temperature >38oC

    for 2-7 days- Chills- Diarrhea- Non-productive

    cough 2-7 days- hypoxia- positive diagnostic

    test

    After 8 hours of nursingintervention, the patientwill be able to maintainnormal body

    temperature of 36-35oCAnd reduce therespiratory symptoms.

    INDEPENDENT:1.) Monitor lung soundsand cough

    2.) MonitorTemperature

    3.) Monitor oxygensaturation

    4.) Maintain respiratorycirculation:

    keep tissues on thebedside dispose secretionsproperly

    have the patientcover mouth when

    Patient exhibits absenceof fever and absence ofrespiratory symptoms.Risk of spread of

    infections is reduced.The goal was partiallymet.

  • 7/27/2019 SARS powerpoint

    40/44

    As evidenced by: GOAL INTERVENTION EVALUATION

    have the patientcover mouth whensneezing or coughing use masks

    have anyone enteringthe patients room wear

    a mask keep door closed allthe time and placerespiratory isolation

    sign visible assist visitors tofollow appropriateisolation techniques

    5.) teach the patient towash hands after

    coughing

  • 7/27/2019 SARS powerpoint

    41/44

    As evidenced by: GOAL INTERVENTION EVALUATION

    6.) use appropriatetherapy to decreasetemperature

    7.) encourage thepatient to cough unlessthe cough isnonproductive

    8.) for patients withreduced energy, paceactivities

    9.) provide a high-protein , high calorie,increase fluid diet insmall frequent servings.

  • 7/27/2019 SARS powerpoint

    42/44

    As evidenced by: GOAL INTERVENTION EVALUATION

    DEPENDENT:

    1.) Administer antiviralmedications as ordered.

    COLLABORATIVE:1.) Consult a respiratorytherapist for chestphysiotherapy andnebulizer treatments

    2.) Collect and monitordiagnostic results

  • 7/27/2019 SARS powerpoint

    43/44

    ovel Corona virus Well-Adapted

    to Humans, Susceptible to

    ImmunotherapyFeb. 19, 2013 The new coronavirus that has emerged

    in the Middle East is well-adapted to infecting humans

    but could potentially be treated with immunotherapy,

    according to a study to be published on February 19

    in mBio, the online open-access journal of the

    American Society for Microbiology. The study indicates

    that the virus HCoV-EMC can penetrate the lining of thepassageways in the lung and evade the innate immune

    system as easily as a cold virus can, signs that HCoV-EMC

    is well-equipped for infecting human cells. The study

    also reveals that the virus is susceptible to treatment

    with interferons, components of the immune system

    that have been used successfully to treat other viraldiseases, opening a possible mode of treatment in the

    event of a large-scale outbreak.

    American Society for Microbiology (2013, February 19).

    Novel coronavirus well-adapted to humans, susceptible

    to immunotherapy.ScienceDaily. Retrieved August 7,

    2013, from http://www.sciencedaily.com-

    /releases/2013/02/130219091010.htm

  • 7/27/2019 SARS powerpoint

    44/44